TLR2 and cancer: (104) demonstrated that overexpressed HSP70 on the sEV membrane secreted by some cancer cells was able to bind to Toll-like receptor 2 to activate myeloid-derived suppressor cells, consequently, inhibiting immune cell response and promoting tumor progression.